Arbe Announces Q1 2024 Financial Results

TEL AVIV, Israel, May 22, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in Perception Radar Solutions, today announced financial results for its first quarter, which ended March 31, 2024.

https://mma.prnewswire.com/media/803813/Arbe_Robotics_Logo.jpg

Key Q1 and Recent Company Highlights:

    --  A global leader in autonomous driving selected the HiRain LRR610 radar,
        powered by the Arbe chipset for its robotaxi fleet scheduled for mass
        production in 2025.
    --  Arbe's finalized chipsets, which are nearing full automotive
        qualification, are advancing to volume production, with our Tier 1s
        actively completing the radar hardware and software for design
        validation tests and preparation for serial production.
    --  During the first quarter, we actively supported leading OEMs in their
        evaluation and RFP/RFQ processes in collaboration with our Tier 1s:
        Magna, HiRain, Weifu, and Sensrad. We believe the demand for
        high-channel count solutions is widespread across the board, and the
        Arbe solution is recognized as the radar with the largest channel array
        by leading OEMs.
    --  A large Japanese automotive client is working to complete a massive data
        collection initiative with Arbe radar solution this year, as part of the
        development of an advanced ADAS/AD architecture.
    --  NVIDIA has brought together a select group of advanced digital sensors
        from industry leaders, including Arbe's Perception Radar, to create a
        rich ecosystem of simulation tools and applications as part of the
        Omniverse Cloud APIs, designed to accelerate the path to autonomy.
    --  Horizon Robotics, the premier provider of computing solutions for ADAS
        and AD, presented the integration of Weifu's 4D Imaging Radar, powered
        by the Arbe chipset, with Horizon's Journey 6 Automotive AI processor,
        as part of their partner ecosystem at the 2024 Beijing International
        Automotive Exhibition.
    --  Arbe's technology provides the leading solution for tracking pedestrians
        and vehicles in challenging weather and lighting conditions. We believe
        this capability is crucial for meeting the requirements of the NHTSA's
        new federal safety standard, which mandates automatic emergency braking
        (AEB), including pedestrian AEB, for all passenger cars and light trucks
        by September 2029.
    --  HiRain achieved a significant milestone by successfully developing
        state-of-the-art post-point cloud algorithms, including clustering,
        tracking, classification, and free space analysis, for its LRR610 radar
        powered by the Arbe chipset. These innovations have been piloted with
        leading OEMs, showcasing their potential impact on automotive safety.
    --  Arbe is in the process of dual listing on the Tel Aviv Stock Exchange
        (TASE) to enhance trading volume. Concurrently, the company is advancing
        towards a convertible bonds issuance on the TASE, to secure sufficient
        working capital and to support Tier 1s, customers, and anticipated
        production ramp up in 2025.

"In the first quarter, most leading OEMs progressed towards selecting high-definition radar systems leveraging a high channel count chipset. This validates the indispensability of our technology for safe, hands-free driving," stated Kobi Marenko, Chief Executive Officer. "We are proud to offer a pivotal sensor that empowers OEMs to adhere to the latest NHTSA safety standards, enabling crucial AEB functionalities and advanced safety features such as night-time pedestrian and vehicle detection."

First Quarter 2024 Financial Highlights

Revenues for Q1 2024 were $0.1 million, a decrease from $0.4 million in Q1 2023. Backlog as of March 31, 2024, was $1.0 million.

Negative gross margin for Q1 2024 was 194%, compared to positive gross margin of 11% in Q1 2023, mainly related to a reduction in revenue as well as an increase in our workforce.

Operating expenses in Q1 2024 were $12.5 million, compared to $10.7 million in Q1 2023. The increase in operating expenses was primarily driven by an increase in non-cash shared-based compensation expenses. Research and Development increased, from $8.1 million in Q1 2023 to $9.4 million in Q1 2024, mainly related to non-cash shared based compensation expenses. Sales and Marketing expenses increased from $0.9 million in Q1 2023 to $1.5 million in Q1 2024, related to the share-based compensation increase and an increase in labor cost. General and Administrative expenses remained at the same level in both Q1 2023 and Q1 2024 at $1.6 million.

As a result, our operating loss in Q1 2024 was $12.8 million compared to $10.6 million loss in Q1 2023.

Net loss in Q1 2024 increased to $12.8 million, compared to a net loss of $9.9 million in Q1 2023. Net loss in Q1 2024 included $45 thousand of financial expenses, compared to $0.7 million of financial income in Q1 2023. Financial expenses in Q1 2024 included exchange rate revaluation expenses partially offset by interest from deposits and warrants revaluations. Financial income in Q1 2023 mainly related to favorable exchange rates and interest from deposits.

Adjusted EBITDA, a non-GAAP measurement which excludes expenses for non-cash share-based compensation and for non-recurring items, for Q1 2024, yielded a loss of $8.5 million, similar to a loss of $8.4 million in Q1 2023.

Balance Sheet and Liquidity

As of March 31, 2024, Arbe had $5.4 million in cash and cash equivalents and $30.3 million in short term bank deposits with no debt.

Outlook

    --  Our goal of achieving 4 design-ins with automakers remains unchanged, as
        we observe continued strong interest in our market-leading offering.
    --  We have strengthened our position in all our RFQ engagements, even
        though the OEMs shifted their decision timelines from late 2023 to 2024.
    --  The 2024 annual revenues are expected to be in line with those of 2023,
        followed by revenue growth in 2025. These revenue projections are based
        on the intention to be in full production in the second half of 2024, as
        well as our decision to exclusively focus on getting our chipset into
        production.
    --  We are committed to maintaining a strong and well-managed balance sheet,
        focusing on cost-effectiveness and the ability to fund our revenue
        growth. Adjusted EBITDA for 2024 is projected to be in the range of
        ($30) million to ($36) million.

Conference Call & Webcast Details

Arbe will host a conference call and webcast today at 8:30 am ET. Speakers will include Kobi Marenko, Chief Executive Officer, Co-Founder and Director, and Karine Pinto-Flomenboim, Chief Financial Officer. The Company encourages participants to pre-register for the conference call here. Callers will receive a unique dial-in upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

The live call may be accessed via:

U.S. Toll Free: (844) 481-3015
International: (412) 317-1880
Israel Toll Free: (80) 921-2373

A telephonic replay of the conference call will be available until June 5, 2024, following the end of the conference call. To listen to the replay, please dial:

U.S. Toll Free: (877) 344-7529
International: (412) 317-0088
Access ID: 4712793

A live webcast of the call can be accessed here or from Arbe's Investor Relations website at https://ir.arberobotics.com/news/ir-calendar. An archived webcast of the conference call will also be made available on the website following the call.

About Arbe

Arbe (Nasdaq: ARBE), a global leader in Perception Radar Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe's radar technology is 100 times more detailed than any other radar on the market and is a critical sensor for L2+ and higher autonomy. The company is empowering automakers, Tier-1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. Arbe, a leader in the fast-growing automotive radar market, is based in Tel Aviv, Israel, and has offices in China, Germany, and the United States.

Cautionary Note Regarding Forward-Looking Statements

This press release and any statements made at the conference call and webcast referred to in this press release, contains "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, but are not limited to effect on the Israeli economy generally and on Arbe's business resulting from the terrorism and the hostilities in Israel and with its neighboring countries including the effects of the continuing war with Hamas and any further intensification of hostilities with others, including Iran and Hezbollah and the effect of the call-up of a significant portion of its working population, including Arbe's employees; the effect of any potential boycott of Israeli products and business; the effect of any downgrading of the Israeli economy and the effect of changes in the exchange ratio between the US dollar and the Israeli shekel; Arbe's ability to generate firm orders from the Tier-1s who are incorporating its chipset in the radar products they are marketing to automobile manufacturers; the success of Arbe's Tier-1s to market and sell product that are based on its chipset; Arbe's ability to raise funds on terms that are acceptable and do not have a negative impact on the stock price; and the risk and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 3. Key Information - D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" in Arbe's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on March 28, 2024, as well as other documents filed by Arbe with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and Arbe does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Information contained on, or that can be accessed through, Arbe's website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.


                                     
            
              CONSOLIDATED BALANCE SHEETS



     
              (U.S. dollars in thousands)


                                                                                        March 31, 2024 December 31, 2023



     
              
                Current Assets:                                             (Unaudited)      (Unaudited)



     Cash and cash equivalents                                                                  5,131             28,587



     Restricted cash                                                                              260                163



     Short term Bank deposits                                                                  30,304             15,402



     Trade receivable                                                                             856              1,258



     Prepaid expenses and other receivables                                                     2,198              2,026



     Total current assets                                                                      38,749             47,436





     
              
                Non-Current Assets



     Operating lease right-of-use assets                                                        2,034              1,740



     Property and equipment, net                                                                1,263              1,309



     Total non-current assets                                                                   3,297              3,049





     
              Total assets                                                                   42,046             50,485





     
              
                Current liabilities:



     Trade payables                                                                             1,681              1,149



     Operating lease liabilities                                                                  543                436



     Employees and payroll accruals                                                             3,061              2,916



     Accrued expenses and other payables                                                        1,015              1,710



     Total current liabilities                                                                  6,300              6,211



     Total current liabilities




                                 
            
              
                Long term liabilities



     Operating lease liabilities                                                                1,622              1,306



     Warrant liabilities                                                                          763                875



     Total long-term liabilities                                                                2,385              2,181




                                        
            
              SHAREHOLDERS' EQUITY:



     Ordinary Shares                                                                     
             *)       
            *)



     Additional paid-in capital                                                               249,807            245,733



     Accumulated Deficit                                                                    (216,446)         (203,640)



     Total shareholders' equity                                                                33,361             42,093





     
              Total liabilities and shareholders' equity                                     42,046             50,485





     *) Represents less than $1.


                              
              
                CONSOLIDATED STATEMENTS OF OPERATIONS



              
                (U.S. dollars in thousands, except share and per share data)




                                                                                             3 Months Ended 3 Months Ended


                                                                                            March 31, 2024  March 31, 2023


                                                                                               (Unaudited)    (Unaudited)



              Revenues                                                                                 137             355



              Cost of revenues                                                                         403             316



              
                Gross loss (profit)                                                       (266)             39





              Operating Expenses:



              Research and development, net                                                          9,397           8,124



              Sales and marketing                                                                    1,453             924



              General and administrative                                                             1,644           1,630



              Total operating expenses                                                              12,494          10,678





              
                Operating loss                                                         (12,760)       (10,639)





              financing expenses (loss), net                                                            45           (732)





              
                Net loss                                                               (12,805)        (9,907)





              Basic net loss per ordinary share                                                      -0.16           -0.15





              Weighted-average number of                                                        78,176,210      64,671,688
    shares used in computing basic
    net loss per ordinary share





              Diluted net loss per ordinary share                                                    -0.21           -0.17





              Weighted-average number of                                                        62,573,715      58,969,265
    shares used in computing diluted
    net loss per ordinary share


                                                      
              
                CONSOLIDATED STATEMENTS OF CASH FLOWS



     
                (U.S. dollars in thousands)


                                                                                                                     3 Months Ended 3 Months Ended


                                                                                                                    March 31, 2024  March 31, 2023



     
                Cash flows from operating activities:                                                               (Unaudited)    (Unaudited)



     Net Loss                                                                                                             (12,805)        (9,907)





     Adjustments to reconcile loss to net cash used in operating activities:



     Depreciation                                                                                                              142             137



     Stock-based compensation                                                                                                3,726           2,008



     Warrants to service providers                                                                                             348              97



     Revaluation of warrants and accretion                                                                                   (112)            131



     Change in operating assets and liabilities:



     Decrease in trade receivable                                                                                              402             114



     Decrease (increase) in prepaid expenses and other receivables                                                           (172)            174



     Operating lease ROU assets and liabilities, net                                                                           129               8



     Increase in trade payables                                                                                                517             853



     Increase (decrease) in employees and payroll accruals                                                                     145           (593)



     Decrease in accrued expenses and other payables                                                                         (695)        (3,207)





     Net cash used in operating activities                                                                                 (8,376)       (10,185)





     
                Cash flows from investing activities:



     Change in bank deposits                                                                                              (14,902)            400



     Purchase of property and equipment                                                                                       (81)           (53)



     Net cash provided by (used in) investing activities                                                                  (14,983)            347





     
                Cash flows from financing activities:



     Proceeds from exercise of options                                                                                                        561





     Net cash provided by financing activities                                                                                                561





     Effect of exchange rate fluctuations on cash and cash equivalent                                                          256             509





     Decrease in cash, cash equivalents and restricted cash                                                               (23,615)        (9,786)



     Cash, cash equivalents and restricted cash at the beginning of period                                                  28,750          54,315





     
                Cash, cash equivalents and restricted cash at the end of period                                            5,391          45,038


                                                  
              
                RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS



              
                (U.S. dollars in thousands, except share and per share data)




                                                                                                                                3 Months Ended 3 Months Ended


                                                                                                                               March 31, 2024  March 31, 2023



              GAAP net loss attributable to ordinary shareholders                                                                    (12,805)        (9,907)





              Add:



              Stock-based compensation                                                                                                  3,726           2,008



              Warrants to service providers                                                                                               348              97



              Revaluation of warrants and accretion                                                                                     (112)            131



              
                Non-GAAP net loss                                                                                          (8,842)        (7,671)





              Basic Non-GAAP net loss per ordinary share                                                                                -0.11           -0.12





              Weighted-average number of shares used in computing basic                                                            78,176,210      64,671,688
    Non-GAAP net loss per ordinary share





              Diluted Non-GAAP net loss per ordinary share                                                                              -0.14           -0.13





              Weighted-average number of shares used in computing diluted                                                          62,573,715      58,969,265
    Non-GAAP net loss per ordinary share




                                                   
              
                RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA



              
                (U.S. dollars in thousands)




                                                                                                                                3 Months Ended 3 Months Ended


                                                                                                                               March 31, 2024  March 31, 2023



              GAAP net loss attributable to ordinary shareholders                                                                    (12,805)        (9,907)





              Add:



              Financial expenses (income), net                                                                                             45           (732)



              Depreciation                                                                                                                142             137



              Stock-based compensation                                                                                                  3,726           2,008



              Warrants to service providers                                                                                               348              97



              
                Adjusted EBITDA                                                                                            (8,544)        (8,397)

Logo: https://mma.prnewswire.com/media/803813/Arbe_Robotics_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/arbe-announces-q1-2024-financial-results-302152684.html

SOURCE Arbe